Literature DB >> 28448685

Adult neurobehavioral alterations in male and female mice following developmental exposure to paracetamol (acetaminophen): characterization of a critical period.

Gaëtan Philippot1, Torsten Gordh2, Anders Fredriksson3, Henrik Viberg1.   

Abstract

Paracetamol (acetaminophen) is a widely used non-prescription drug with analgesic and antipyretic properties. Among pregnant women and young children, paracetamol is one of the most frequently used drugs and is considered the first-choice treatment for pain and/or fever. Recent findings in both human and animal studies have shown associations between paracetamol intake during brain development and adverse behavioral outcomes later in life. The present study was undertaken to investigate if the induction of these effects depend on when the exposure occurs during a critical period of brain development and if male and female mice are equally affected. Mice of both sexes were exposed to two doses of paracetamol (30 + 30 mg kg-1 , 4 h apart) on postnatal days (PND) 3, 10 or 19. Spontaneous behavior, when introduced to a new home environment, was observed at the age of 2 months. We show that adverse effects on adult behavior and cognitive function occurred in both male and female mice exposed to paracetamol on PND 3 and 10, but not when exposed on PND 19. These neurodevelopmental time points in mice correspond to the beginning of the third trimester of pregnancy and the time around birth in humans, supporting existing human data. Considering that paracetamol is the first choice treatment for pain and/or fever during pregnancy and early life, these results may be of great importance for future research and, ultimately, for clinical practice.
Copyright © 2017 John Wiley & Sons, Ltd. Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Paracetamol (acetaminophen); cognitive impairments; critical period; developmental neurotoxicity; habituation; neonatal mice; spontaneous behavior

Mesh:

Substances:

Year:  2017        PMID: 28448685     DOI: 10.1002/jat.3473

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  12 in total

1.  Associations of acetaminophen use during pregnancy and the first year of life with neurodevelopment in early childhood.

Authors:  Andréa D Bertoldi; Sheryl L Rifas-Shiman; Alexandra Crispim Boing; Tatiane da Silva Dal Pizzol; Vanessa Iribarrem Avena Miranda; Marysabel Pinto Telis Silveira; Mariângela Freitas Silveira; Marlos R Domingues; Ina S Santos; Diego G Bassani; Luciana Tovo-Rodrigues; Emily Oken
Journal:  Paediatr Perinat Epidemiol       Date:  2020-01-22       Impact factor: 3.980

Review 2.  Paracetamol (acetaminophen) use in infants and children was never shown to be safe for neurodevelopment: a systematic review with citation tracking.

Authors:  Jasmine Cendejas-Hernandez; Joshua T Sarafian; Victoria G Lawton; Antara Palkar; Lauren G Anderson; Vincent Larivière; William Parker
Journal:  Eur J Pediatr       Date:  2022-02-17       Impact factor: 3.860

Review 3.  Extrahepatic toxicity of acetaminophen: critical evaluation of the evidence and proposed mechanisms.

Authors:  Stefanie Kennon-McGill; Mitchell R McGill
Journal:  J Clin Transl Res       Date:  2017-11-18

4.  A Single δ9-Tetrahydrocannabinol (THC) Dose During Brain Development Affects Markers of Neurotrophy, Oxidative Stress, and Apoptosis.

Authors:  Gaëtan Philippot; Erica Forsberg; Caroline Tahan; Henrik Viberg; Robert Fredriksson
Journal:  Front Pharmacol       Date:  2019-10-04       Impact factor: 5.810

Review 5.  Paracetamol (Acetaminophen) and the Developing Brain.

Authors:  Christoph Bührer; Stefanie Endesfelder; Till Scheuer; Thomas Schmitz
Journal:  Int J Mol Sci       Date:  2021-10-15       Impact factor: 5.923

6.  Associations of prenatal or infant exposure to acetaminophen or ibuprofen with mid-childhood executive function and behaviour.

Authors:  Sheryl L Rifas-Shiman; Andres Cardenas; Marie-France Hivert; Henning Tiemeier; Andrea D Bertoldi; Emily Oken
Journal:  Paediatr Perinat Epidemiol       Date:  2019-10-21       Impact factor: 3.980

7.  Therapeutic doses of acetaminophen with co-administration of cysteine and mannitol during early development result in long term behavioral changes in laboratory rats.

Authors:  Navneet Suda; Jasmine Cendejas Hernandez; John Poulton; John P Jones; Zacharoula Konsoula; Caroline Smith; William Parker
Journal:  PLoS One       Date:  2021-06-25       Impact factor: 3.240

8.  Is intrauterine exposure to acetaminophen associated with emotional and hyperactivity problems during childhood? Findings from the 2004 Pelotas birth cohort.

Authors:  Luciana Tovo-Rodrigues; Bruna Celestino Schneider; Thais Martins-Silva; Bianca Del-Ponte; Christian Loret de Mola; Lavinia Schuler-Faccini; Fernanda Sales Luiz Vianna; Tiago N Munhoz; Ludmila Entiauspe; Mariângela Freitas Silveira; Iná S Santos; Alicia Matijasevich; Aluísio J D Barros; Luis Augusto Rohde; Andréa Dâmaso Bertoldi
Journal:  BMC Psychiatry       Date:  2018-11-20       Impact factor: 3.630

9.  Postnatal Acetaminophen and Potential Risk of Autism Spectrum Disorder among Males.

Authors:  Seth S Bittker; Kathleen R Bell
Journal:  Behav Sci (Basel)       Date:  2020-01-01

10.  Prenatal and postnatal exposure to acetaminophen in relation to autism spectrum and attention-deficit and hyperactivity symptoms in childhood: Meta-analysis in six European population-based cohorts.

Authors:  Silvia Alemany; Claudia Avella-García; Zeyan Liew; Raquel García-Esteban; Kosuke Inoue; Tim Cadman; Mònica López-Vicente; Llúcia González; Isolina Riaño Galán; Ainara Andiarena; Maribel Casas; Katerina Margetaki; Katrine Strandberg-Larsen; Deborah A Lawlor; Hanan El Marroun; Henning Tiemeier; Carmen Iñiguez; Adonina Tardón; Loreto Santa-Marina; Jordi Júlvez; Daniela Porta; Leda Chatzi; Jordi Sunyer
Journal:  Eur J Epidemiol       Date:  2021-05-28       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.